“…Regarding the secondary outcomes, the detailed comparisons of the efficacies of different drugs were as presented in Appendix A7. Table 2 shows the interventions, the number of trials and participants, and the results of the secondary outcomes (incidence of ED, 8,24,26–28,30,31,33,48,49,52–63 incidence of PONV in PACU, 23,28,31,38,41,42,55,59,61–64 need for rescue analgesia in PACU, 31,38,41,53,55,59,62,63,65 length of stay in PACU, 29,31,39,40,52–54,57–59,61–63,65 changes in SBP after interventions, 23,40,50,51,57,66,67 changes in HR after interventions, 8,23,25,26,40,50,51,53–55,57,64,66–68 and changes in SPO 2 after intervention 8,23,40,51,64 ). Individual rank plots and SUCRA for the secondary outcomes were as shown in Appendices A9 and A10.…”